Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific.
Michea P, Noël F, Zakine E, Czerwinska U, Sirven P, Abouzid O, Goudot C, Scholer-Dahirel A, Vincent-Salomon A, Reyal F, Amigorena S, Guillot-Delost M, Segura E, Soumelis V. Michea P, et al. Among authors: guillot delost m. Nat Immunol. 2018 Aug;19(8):885-897. doi: 10.1038/s41590-018-0145-8. Epub 2018 Jul 16. Nat Immunol. 2018. PMID: 30013147
Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.
Guillot-Delost M, Guilleré L, Berger F, Ventre A, Michea P, Sirven P, Pattarini L, Scholer-Dahirel A, Kebir FZ, Huerre M, Chouchane-Mlik O, Lappartient E, Rodriguez J, Jouffroy T, Klijanienko J, Nicolas A, Sastre-Garau X, Honorio S, Mosseri V, Le Peltier N, Sablin MP, Le Tourneau C, Tartour É, Badoual C, Soumelis V. Guillot-Delost M, et al. Oncoimmunology. 2016 Jun 7;5(7):e1179414. doi: 10.1080/2162402X.2016.1179414. eCollection 2016 Jul. Oncoimmunology. 2016. PMID: 27622034 Free PMC article.
No evidence for TSLP pathway activity in human breast cancer.
Ghirelli C, Sadacca B, Reyal F, Zollinger R, Michea P, Sirven P, Pattarini L, Martínez-Cingolani C, Guillot-Delost M, Nicolas A, Scholer-Dahirel A, Soumelis V. Ghirelli C, et al. Among authors: guillot delost m. Oncoimmunology. 2016 May 9;5(8):e1178438. doi: 10.1080/2162402X.2016.1178438. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622057 Free PMC article.
A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer.
Faucheux L, Grandclaudon M, Perrot-Dockès M, Sirven P, Berger F, Hamy AS, Fourchotte V, Vincent-Salomon A, Mechta-Grigoriou F, Reyal F, Scholer-Dahirel A, Guillot-Delost M, Soumelis V. Faucheux L, et al. Among authors: guillot delost m. Oncoimmunology. 2019 Jun 24;8(9):e1624130. doi: 10.1080/2162402X.2019.1624130. eCollection 2019. Oncoimmunology. 2019. PMID: 31428522 Free PMC article.
MMP2 as an independent prognostic stratifier in oral cavity cancers.
Hoffmann C, Vacher S, Sirven P, Lecerf C, Massenet L, Moreira A, Surun A, Schnitzler A, Klijanienko J, Mariani O, Jeannot E, Badois N, Lesnik M, Choussy O, Le Tourneau C, Guillot-Delost M, Kamal M, Bieche I, Soumelis V. Hoffmann C, et al. Among authors: guillot delost m. Oncoimmunology. 2020 May 13;9(1):1754094. doi: 10.1080/2162402X.2020.1754094. Oncoimmunology. 2020. PMID: 32934875 Free PMC article.
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity.
Hoffmann C, Noel F, Grandclaudon M, Massenet-Regad L, Michea P, Sirven P, Faucheux L, Surun A, Lantz O, Bohec M, Ye J, Guo W, Rochefort J, Klijanienko J, Baulande S, Lecerf C, Kamal M, Le Tourneau C, Guillot-Delost M, Soumelis V. Hoffmann C, et al. Among authors: guillot delost m. Nat Commun. 2022 Apr 13;13(1):1983. doi: 10.1038/s41467-022-29516-w. Nat Commun. 2022. PMID: 35418195 Free PMC article.
Definition of a novel breast tumor-specific classifier based on secretome analysis.
Sirven P, Faucheux L, Grandclaudon M, Michea P, Vincent-Salomon A, Mechta-Grigoriou F, Scholer-Dahirel A, Guillot-Delost M, Soumelis V. Sirven P, et al. Among authors: guillot delost m. Breast Cancer Res. 2022 Dec 20;24(1):94. doi: 10.1186/s13058-022-01590-4. Breast Cancer Res. 2022. PMID: 36539890 Free PMC article.
High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.
Anna F, Goyard S, Lalanne AI, Nevo F, Gransagne M, Souque P, Louis D, Gillon V, Turbiez I, Bidard FC, Gobillion A, Savignoni A, Guillot-Delost M, Dejardin F, Dufour E, Petres S, Richard-Le Goff O, Choucha Z, Helynck O, Janin YL, Escriou N, Charneau P, Perez F, Rose T, Lantz O. Anna F, et al. Among authors: guillot delost m. Eur J Immunol. 2021 Jan;51(1):180-190. doi: 10.1002/eji.202049058. Epub 2020 Dec 23. Eur J Immunol. 2021. PMID: 33259646 Free PMC article.
17 results